Is Myasthenia Gravis a Real Complication of the COVID-19 Vaccine? A Case Report-Based Systematic Review

Table 3

Quality assessment based on the JBI tool for case series.

	Abdulla Watada et al
1. Were there clear criteria for inclusion in the case series?	Yes
2. Was the condition measured in a standard, reliable way for all participants included in the case series?	Yes
3. Were valid methods used for the identification of the condition for all participants included in the case series?	Yes
4. Did the case series have consecutive inclusion of participants?	Yes
5. Did the case series have complete inclusion of participants?	Yes
6. Was there clear reporting of the demographics of the participants in the study?	Yes
7. Was there clear reporting of clinical information of the participants?	Not clear
8. Were the outcomes or follow-up results of cases clearly reported?	Yes
9. Was there clear reporting of the presenting site (s)/clinic (s) demographic information?	Yes
10. Was statistical analysis appropriate?	Yes
Overall	9 out of 10